glp-1/gip vs tirzepatide Comparison between GLP-1 RA and the dual agonist Tirzepatide: A Double Approach to

Steinberg, H

Semaglutide is a powerful tool, but combining it with positive lifestyle changes provides optimal, sustainable results

Currently, the standard recommendation for treatment is: weight loss with diet, exercise

In clinical trials of FDA-approved GLP-1 medications used under medical supervision, some patients achieved average losses consistent with 4 to 8 pounds per month over time, with a total weight loss of roughly 15% to 21% of body weight over the full treatment course

Consequently, we explored the feasibility of appending a lysine (K) to the C-terminal of the Tirzepatide parent peptide to introduce acylated moiety as shown in Fig

Skin feels consistently balanced and looks clearer, more even, and naturally radiant